In this online exclusive, Erik Janssen, vice president of Global New Patient Solutions Neurology at UCB, talks about why advancements in big data and analytics might be the key to helping patients with epilepsy.
The recent collaboration between Merck and InnoCore Pharmaceuticals for the development of a new drug delivery platform that will improve compliance could be a step forward in the delivery of biologics, according to GlobalData
Dr Stuart Ward, head of business analysis at IDBS, discusses why organisations should be considering transitioning to cloud-based software and technologies and some of the important things they should keep in mind.
Bryan Plaster, VP Customer Services at Trifacta, tells us more about how establishing a centre of excellence (CoE) for data analytics can help organisations accelerate research & development (R&D).
We have now passed the six month point before the Falsified Medicines Directive (FMD) comes into force. In this online exclusive, Mark Davison, senior operations director, rfxcel insists you ACT NOW! Here are six short reflections.
Earlier this year, the European Commission proposed the introduction of a manufacturing exemption for SPCs. Here, Alexander Kritharidis, Taylor Wessing, London, who is specialising in patents law, goes into more detail…
Kathryn Moon, Life Science Risk & Insurance specialist at UK broker Gallagher, looks at why it can be essential for businesses in the industry to have a robust insurance policy in place to protect it.
In this article, Chris Maughan — managing director and Autoclave Validation SME at Thermal Compliance — investigates the use of wireless dataloggers for autoclave validation, looking into the how they can help and issues with their use.
Here, Jim Morris from NSF International, summarises the benefits of an excipient GMP certification programme (ECP) both from the point of view of the excipient manufacturer and the excipient customer.
We speak with Sven Poulson, senior director, segment manager — life sciences from Getinge about the company's innovations highlighted at the show, industry trends and what the future holds…
In this article, Dr Malcolm Haddrick (Medicines Discovery Catapult) and Professor Steve Evans (University of Leeds) highlight the exciting and innovative new method of drug delivery — microbubbles.
